IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
Prod uct ranges in clude: phar ma ceu ti cal prod ucts
(branded, pre scrip tion, non-pre scrip tion), hos pi -
tal pharmaceuticals, oph thal mic prod ucts. Es tab -
lished 1987. Di vi sions include: Novartis Beijing.
Con tacts (Pharm): Chair man: Dai Hao Sen,
James Liu; Com mer cial Op er a tions: James Deng;
Man u fac ture: Jurg Steiner; Mar ket Re search:
John son Ye; Gen eral Con tact: Hu Ping
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 150-160 mil lion
Prod ucts (% of Sales by Lead ing 5): 70-75%
Ther a peu tic Classes (% of Sales by Lead ing
5): 70-75%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
DIOVAN (an gio ten sin-II an tag o nist plain)
SANDOSTATIN (hor mone hy po tha lamic)
SANDIMMUN NEORAL (immunosuppressive
agent)
MIACALCIC (calcitonin)
GLIVEC (antineoplastic other)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 23%
hor mones pi tu itary and hy po tha lamic 18%
immunosuppressive agents 18%
hor mones other 10%
antineoplastics 7%
Lead ing Dose Forms:
cap sules 50%
am poules 26%
coated tab lets 7%
in fu sions 6%
tab lets 5%
COLOMBIA
NOVARTIS
Full Name: Novartis de Co lom bia S.A.
Postal Ad dress: Apartado Aereo 12323, Bo gota
Street Ad dress: Calle 11 No. 65-51, Bo gota
12323
Tel: +57 1 420 6100/420 6055
Fax: +57 1 290 2244
Home Page: www.novartis.com.co
De scrip tion: Im porter, dis trib u tor, pro moter,
sales/detailer. Im ports, dis trib utes, pro motes,
sells/de tails for other com pa nies. Prod uct ranges
in clude: phar ma ceu ti cal prod ucts (branded, pre -
scrip tion, non-pre scrip tion), hos pi tal
pharmaceuticals, oph thal mic prod ucts, op ti cal
instruments. Established 1997.
Con tacts (Pharm): Chair man: An dre Brazay;
Com mer cial Op er a tions: Maria Cristina Alvarez;
Mar ket Re search: Beatriz Ramirez Montero; Re -
search & De vel op ment: Maria Cristina Eslava;
Gen eral Con tact: Beatriz Ramirez Montero
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 40-45 mil lion
Prod ucts (% of Sales by Lead ing 5): 35-40%
Ther a peu tic Classes (% of Sales by Lead ing
5): 60-65%
Dose Forms (% of Sales by Lead ing 5):
75-80%
Prin ci pal Prod ucts:
VOLTAREN (antirheumatic non-steroidal)
MEBUCAINA (throat prep a ra tion)
DIOVAN HCT (an gio ten sin-II an tag o nist com bi na -
tion)
DIOVAN (an gio ten sin-II an tag o nist plain)
GENTEAL (ar ti fi cial tears/oc u lar lu bri cant)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 15%
anti rheu ma tics sys temic 14%
ophthalmologicals 14%
throat prep a ra tions 10%
antiepileptics 8%
Lead ing Dose Forms:
coated tab lets 27%
tab lets 20%
liq uids 13%
spe cial solid forms 10%
cap sules 8%
SANDOZ
Street Ad dress: Calle 11 No. 65-51, Bo gota
Tel: +57 1 420 6100/420 6055
Fax: +57 1 420 8309
De scrip tion: Packager/as sem bler, ex porter,
sales/detailer. Man u fac tures, man u fac tures for
other com pa nies. Prod uct ranges in clude: phar -
ma ceu ti cal prod ucts (branded, unbranded, pre -
scrip tion, non-pre scrip tion), hos pi tal
pharmaceuticals. Established 1996.
Con tacts (Pharm): Chair man: Nestor Chavez
Mar ti nez
Phar ma ceu ti cal Sales: US$ 6-7 mil lion
Prod ucts (% of Sales by Lead ing 5): 65-70%
Ther a peu tic Classes (% of Sales by Lead ing
5): 85-90%
Dose Forms (% of Sales by Lead ing 5):
85-90%
Prin ci pal Prod ucts:
© 2009 IMS Health In cor po rated or its af fil i ates Page 159